These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4244392)

  • 1. [Attempted immunological tumor therapy with sensitized allogeneic lymphoid cells in rats with benzopyrene sarcomas].
    Trepel F; Fink U; Ling G; Begemann H
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):395-407. PubMed ID: 4244392
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of isogenic lymphoid cell on primary sarcomas in the rat.
    Blamey RW
    Cancer Res; 1969 Feb; 29(2):333-4. PubMed ID: 4885387
    [No Abstract]   [Full Text] [Related]  

  • 3. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice.
    Ramming KP; Pilch YH
    Surg Forum; 1969; 20():106-9. PubMed ID: 5383020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of tumour homografts by the local graft-versus-host reaction.
    Medzihradský J; Klobusická M; Koníková E; Novotná L
    Neoplasma; 1971; 18(2):133-40. PubMed ID: 4397019
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of tumor-sensitized cells during the induction of permanent tumor regression by chemoimmunotherapy: the use of glucose phosphate isomerase as a marker.
    Evans R; Duffy TM
    Int J Cancer; 1984 Oct; 34(4):575-80. PubMed ID: 6490208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the effect of heparinoid on the distribution of 3 H- and 32 P-labelled cyclophosphamide in the organs of rats with a 3,4-benzopyrene sarcoma].
    Fahr K; Lorenz WJ; Scheer KE
    Nucl Med (Stuttg); 1970 Sep; 9(3):285-93. PubMed ID: 4107248
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA.
    Deckers PJ; Pilch YH
    Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
    Matsumura T; Krinock RA; Chang AE; Shu S
    Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of theta-plus-lymphocytes in the regional and distant lymph nodes C3H/Sn strain mice during development of primary methylcholanthrene sarcomas].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Biull Eksp Biol Med; 1975 Jan; 79(1):57-9. PubMed ID: 1078631
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action.
    Evans R
    J Immunol; 1983 Jun; 130(6):2511-3. PubMed ID: 6133894
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of x-irradiation of recipients on in vivo neutralization of syngeneic tumors by spleen cells nonspecificially immunized with allogeneic tumors.
    Nakayama M; Sendo F; Gotohda E; Kobayashi H
    Gan; 1977 Aug; 68(4):509-12. PubMed ID: 80344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of blocking antibodies in immunological enhancement.
    Takasugi M; Klein E
    Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.